Back to all companies
Sign in
Back to all companies
Biobot Analytics logo

Biobot Analytics

Winter 2018Active

Population health analytics powered by wastewater.

Save
Biobot Analytics logo

Biobot Analytics

Winter 2018Active

Population health analytics powered by wastewater.

Save
Company details

Our mission is to transform wastewater infrastructure into public health observatories.

Named as one of Fast Company’s most innovative companies in the world in 2021, Biobot Analytics is a wastewater epidemiology company and uses technology developed at MIT to measure biomarkers in sewage to better understand population health in cities. We first launched an opioid product to support government and public health officials in responding to the opioid epidemic, and in 2020 launched a Covid19 product to estimate the scope and trend of the outbreak in communities. We have operated in almost 500 communities across 43 U.S. states, generating Covid19 case estimates for over 13% of the U.S. population.

Battling the opioid epidemic and now the Covid19 pandemic is just the beginning - we’re transforming sewage into a data asset and building a public health database. Eventually, Biobot data will be an early warning system for disease outbreaks, a map of nutrition disparities, and more.

Please visit our website at www.biobot.io

Location
Boston, MA, USA
Founded
Unknown
Category
Health Tech
YC Directory Pagebiobot.io
Founders
  • NG
    Newsha Ghaeli
    Cofounder & President
    LinkedIn
  • MM
    Mariana Matus
    Founder
    X / TwitterLinkedIn

Our mission is to transform wastewater infrastructure into public health observatories.

Named as one of Fast Company’s most innovative companies in the world in 2021, Biobot Analytics is a wastewater epidemiology company and uses technology developed at MIT to measure biomarkers in sewage to better understand population health in cities. We first launched an opioid product to support government and public health officials in responding to the opioid epidemic, and in 2020 launched a Covid19 product to estimate the scope and trend of the outbreak in communities. We have operated in almost 500 communities across 43 U.S. states, generating Covid19 case estimates for over 13% of the U.S. population.

Battling the opioid epidemic and now the Covid19 pandemic is just the beginning - we’re transforming sewage into a data asset and building a public health database. Eventually, Biobot data will be an early warning system for disease outbreaks, a map of nutrition disparities, and more.

Please visit our website at www.biobot.io

Location
Boston, MA, USA
Founded
Unknown
Category
Health Tech
YC Directory Pagebiobot.io
Founders
  • NG
    Newsha Ghaeli
    Cofounder & President
    LinkedIn
  • MM
    Mariana Matus
    Founder
    X / TwitterLinkedIn
Pro

Upgrade to Pro, then request the Biobot Analytics teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate Biobot Analytics. The full teardown, rebuild plan, and technical specs unlock when it lands.

  • Use Pro to request the first Biobot Analytics teardown and keep the finished report in your account.
  • Read every completed teardown and rebuild plan already in the database.
  • Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans
Full teardown library
Specs for every company
5 fresh requests / month
CLI for agent imports
Startups.RIP — Dead startups, alive ideas
PricingContactPrivacyGot feedback? DM @oscrhong